Literature DB >> 8277400

Periodontal regeneration of human intrabony defects. IV. Determinants of healing response.

M S Tonetti1, G Pini-Prato, P Cortellini.   

Abstract

The purpose of this study was to identify factors which might affect the healing response in intrabony defects treated with guided tissue regeneration. Selected sites presented with deep periodontal lesions with 1, 2, and 3 wall combination intrabony component of 6.1 +/- 2.5 mm. The significance of patient, tooth, and defect characteristics and surgical parameters as predictor variables affecting the regenerative outcome before and following the removal of the barrier membrane was assessed. Outcome was measured as tissue gain under the membrane, regenerated probing attachment level (PAL), and bone fill. The total depth of the intrabony component and the radiographic defect angle significantly affected the amount of tissue gain. Seventy-five percent (75%) of the variability of regenerated PAL and bone fill was explained in terms of tissue gain under the membrane, radiographic width of the defect angle, full mouth bleeding score, and presence or absence of flap coverage of the newly formed tissue. Control of the identified predictor variables might improve the extent and predictability of guided tissue regeneration in the treatment of deep intrabony defects.

Entities:  

Mesh:

Year:  1993        PMID: 8277400     DOI: 10.1902/jop.1993.64.10.934

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  29 in total

1.  Radiographic outcomes following treatment of intrabony defect with guided tissue regeneration in aggressive periodontitis.

Authors:  Thanasak Rakmanee; Gareth S Griffiths; Gita Auplish; Ulpee Darbar; Aviva Petrie; Irwin Olsen; Nikolaos Donos
Journal:  Clin Oral Investig       Date:  2015-10-10       Impact factor: 3.573

2.  Demineralized freeze-dried bone allograft and platelet-rich plasma vs platelet-rich plasma alone in infrabony defects: a clinical and radiographic evaluation.

Authors:  Tunç Ilgenli; Nesrin Dündar; Betül Ilhan Kal
Journal:  Clin Oral Investig       Date:  2006-12-09       Impact factor: 3.573

Review 3.  Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and meta-analysis.

Authors:  M Matarasso; V Iorio-Siciliano; A Blasi; L Ramaglia; G E Salvi; A Sculean
Journal:  Clin Oral Investig       Date:  2015-05-27       Impact factor: 3.573

4.  Clinical and microbiological changes after minimally invasive therapeutic approaches in intrabony defects: a 12-month follow-up.

Authors:  Fernanda V Ribeiro; Renato C V Casarin; Maria A G Palma; Francisco H N Júnior; Enilson A Sallum; Márcio Z Casati
Journal:  Clin Oral Investig       Date:  2012-10-05       Impact factor: 3.573

5.  Clinical Evaluation of Insulin like Growth Factor-I and Vascular Endothelial Growth Factor with Alloplastic Bone Graft Material in the Management of Human Two Wall Intra-Osseous Defects.

Authors:  Renu Devi; Jaya Dixit
Journal:  J Clin Diagn Res       Date:  2016-09-01

6.  GTR treatment of intrabony defects with PLA/PGA copolymer or collagen bioresorbable membranes in combination with deproteinized bovine bone (Bio-Oss).

Authors:  Andreas Stavropoulos; Anton Sculean; Thorkild Karring
Journal:  Clin Oral Investig       Date:  2004-08-03       Impact factor: 3.573

7.  Long-term outcome following regenerative periodontal treatment of intrabony defects.

Authors:  Kanyawat Rattanasuwan; Krittawat Lertsukprasert; Supanee Rassameemasmaung; Chulaluk Komoltri
Journal:  Odontology       Date:  2016-05-19       Impact factor: 2.634

8.  Treatment of intrabony defects with guided tissue regeneration in aggressive periodontitis: clinical outcomes at 6 and 12 months.

Authors:  Thanasak Rakmanee; Gareth S Griffiths; Gita Auplish; Ulpee Darbar; Aviva Petrie; Irwin Olsen; Nikolaos Donos
Journal:  Clin Oral Investig       Date:  2015-09-28       Impact factor: 3.573

9.  Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 12-month randomized controlled trial.

Authors:  Bartłomiej Górski; Stanisław Jalowski; Renata Górska; Maciej Zaremba
Journal:  Clin Oral Investig       Date:  2018-02-06       Impact factor: 3.573

10.  Clinical evaluation of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of human infrabony defects.

Authors:  Adrian Kasaj; Bernd Röhrig; Christoph Reichert; Brita Willershausen
Journal:  Clin Oral Investig       Date:  2008-03-05       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.